Activity of tedizolid (TR-700) against well-characterized methicillin-resistant staphylococcus aureus strains of diverse epidemiological origins

Kenneth S. Thomson, Richard V. Goering

Research output: Contribution to journalArticle

36 Scopus citations


The in vitro activities of tedizolid and 10 antistaphylococcal agents were compared against 111 methicillin-resistant Staphylococcus aureus (MRSA) strains from 14 epidemiologically characterized groups. Tedizolid, tigecycline, and daptomycin were the most potent agents, with tedizolid 4-fold more potent than linezolid. Tedizolid, linezolid, and vancomycin were unaffected by epidemiological types. Tigecycline and daptomycin had reduced potency against ST80-MRSA-IV and ST239-MRSA-III, respectively. Overall, tedizolid was highly potent against all MRSA strain types, including those resistant to other classes of drugs.

Original languageEnglish
Pages (from-to)2892-2895
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Issue number6
Publication statusPublished - Jun 2013


All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this